Arvinas Stock Price Prediction

ARVN Stock  USD 25.98  1.50  6.13%   
As of today, the relative strength index (RSI) of Arvinas' share price is approaching 43. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Arvinas, making its price go up or down.

Oversold Vs Overbought

43

 
Oversold
 
Overbought
The successful prediction of Arvinas' future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with Arvinas, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Arvinas' stock price prediction:
EPS Estimate Next Quarter
(1.02)
EPS Estimate Current Year
(3.16)
EPS Estimate Next Year
(4.69)
Wall Street Target Price
62.9474
EPS Estimate Current Quarter
(0.96)
Using Arvinas hype-based prediction, you can estimate the value of Arvinas from the perspective of Arvinas response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Arvinas to buy its stock at a price that has no basis in reality. In that case, they are not buying Arvinas because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Arvinas after-hype prediction price

    
  USD 25.98  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Arvinas Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Arvinas' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
23.3835.4738.93
Details
Naive
Forecast
LowNextHigh
22.8626.3129.77
Details
21 Analysts
Consensus
LowTargetHigh
59.1565.0072.15
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-1.11-0.79-0.52
Details

Arvinas After-Hype Price Prediction Density Analysis

As far as predicting the price of Arvinas at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Arvinas or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Arvinas, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Arvinas Estimiated After-Hype Price Volatility

In the context of predicting Arvinas' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Arvinas' historical news coverage. Arvinas' after-hype downside and upside margins for the prediction period are 22.52 and 29.44, respectively. We have considered Arvinas' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
25.98
25.98
After-hype Price
29.44
Upside
Arvinas is very steady at this time. Analysis and calculation of next after-hype price of Arvinas is based on 3 months time horizon.

Arvinas Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Arvinas is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Arvinas backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Arvinas, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.05 
3.48
 0.00  
  0.01 
10 Events / Month
13 Events / Month
In about 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
25.98
25.98
0.00 
8,700  
Notes

Arvinas Hype Timeline

Arvinas is presently traded for 25.98. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Arvinas is anticipated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is anticipated to be very small, whereas the daily expected return is presently at 0.05%. %. The volatility of related hype on Arvinas is about 1717.11%, with the expected price after the next announcement by competition of 25.97. About 93.0% of the company shares are held by institutions such as insurance companies. The book value of Arvinas was presently reported as 8.53. The company has Price/Earnings To Growth (PEG) ratio of 0.28. Arvinas recorded a loss per share of 4.79. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next anticipated press release will be in about 10 days.
Check out Arvinas Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.

Arvinas Related Hype Analysis

Having access to credible news sources related to Arvinas' direct competition is more important than ever and may enhance your ability to predict Arvinas' future price movements. Getting to know how Arvinas' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Arvinas may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
CCCCC4 Therapeutics(0.35)10 per month 0.00 (0.16) 7.69 (7.98) 23.66 
GLUEMonte Rosa Therapeutics(0.74)8 per month 4.03  0.06  7.42 (8.18) 102.66 
NRIXNurix Therapeutics 0.02 8 per month 0.00 (0.09) 5.22 (4.73) 22.77 
FHTXFoghorn Therapeutics(0.47)10 per month 0.00 (0.03) 8.50 (6.81) 34.64 
RLAYRelay Therapeutics(0.03)11 per month 0.00 (0.07) 4.82 (6.29) 66.18 
STOKStoke Therapeutics(0.04)10 per month 0.00 (0.09) 4.68 (6.99) 21.35 
PLRXPliant Therapeutics 0.22 9 per month 3.19 (0.02) 5.37 (5.55) 24.35 
BDTXBlack Diamond Therapeutics 0.18 7 per month 0.00 (0.35) 5.47 (8.30) 19.51 
STTKShattuck Labs(0.01)10 per month 0.00 (0.18) 6.93 (9.82) 51.03 
KYMRKymera Therapeutics(0.63)11 per month 0.00 (0.07) 4.84 (4.74) 18.10 
RAREUltragenyx(0.10)11 per month 0.00 (0.21) 2.65 (3.20) 8.73 
CRNXCrinetics Pharmaceuticals(1.87)11 per month 2.46 (0.0005) 3.67 (3.45) 16.75 
RVMDRevolution Medicines 1.10 9 per month 2.03  0.13  4.81 (3.24) 10.95 
KURAKura Oncology(0.33)8 per month 0.00 (0.18) 4.98 (4.04) 42.52 
IPSCCentury Therapeutics 0.01 10 per month 0.00 (0.13) 6.21 (8.82) 21.67 

Arvinas Additional Predictive Modules

Most predictive techniques to examine Arvinas price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Arvinas using various technical indicators. When you analyze Arvinas charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Arvinas Predictive Indicators

The successful prediction of Arvinas stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Arvinas, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Arvinas based on analysis of Arvinas hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Arvinas's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Arvinas's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding200.8722.2233.4831.8
PTB Ratio5.253.223.463.29

Story Coverage note for Arvinas

The number of cover stories for Arvinas depends on current market conditions and Arvinas' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Arvinas is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Arvinas' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Arvinas Short Properties

Arvinas' future price predictability will typically decrease when Arvinas' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Arvinas often depends not only on the future outlook of the potential Arvinas' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Arvinas' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding55.5 M
Cash And Short Term Investments1.3 B
When determining whether Arvinas offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Arvinas' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Arvinas Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Arvinas Stock:
Check out Arvinas Basic Forecasting Models to cross-verify your projections.
To learn how to invest in Arvinas Stock, please use our How to Invest in Arvinas guide.
You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arvinas. If investors know Arvinas will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arvinas listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.79)
Revenue Per Share
2.327
Quarterly Revenue Growth
1.96
Return On Assets
(0.20)
Return On Equity
(0.59)
The market value of Arvinas is measured differently than its book value, which is the value of Arvinas that is recorded on the company's balance sheet. Investors also form their own opinion of Arvinas' value that differs from its market value or its book value, called intrinsic value, which is Arvinas' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arvinas' market value can be influenced by many factors that don't directly affect Arvinas' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arvinas' value and its price as these two are different measures arrived at by different means. Investors typically determine if Arvinas is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arvinas' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.